Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous
Recruiting now · Not applicable
Conditions studied: Systemic Lupus Erthematosus (SLE)
In brief
To study the effect of anti-inflammatory diet on clinical and biological outcomes in lupus
Key facts
- Study ID
- NCT07713940
- Run by
- University of California, San Diego
- People needed
- 36
- Starts
- 2026-07-01
- Expected to finish
- 2029-07-01
- Last updated by the study team
- 2026-07-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patients who meet the 2019 EULAR/ACR Classification Criteria for SLE
- patients who are on Cellcept or Myfortic for at least 3 months prior to screening
- patients with a score of ≥55 on the Patient Reported Outcomes Measurement Information System (PROMIS) Pain interference scale.
You may not qualify if…
- pregnant or lactating patients,
- patients with food allergy
- patients on antibiotics within 4 weeks of the screening
- patients that change the SLE therapy during the length of the study (12 weeks).
Where it is running
- Altman Clinical Translational Research Insitute (UC San Diego) — La Jolla, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.